Instead, DNA aneuploidy was a stronger indicator of poor prognosis, especially for HER2+/ER-positive tumors, in line with previous reports for breast cancer irrespective of HER2 status [59,60]. The gene discussed is ERBB2; the disease is breast carcinoma.